Register to View Transcatheter and Surgical Aortic Valve Replacement: Patient Characteristics and Outcomes

May 12, 2022

On May 15 – May 18, 2022, this poster was on display at ISPOR 2022.

What is the Objective of this Poster?

  • These results help provide insights into which factors are associated with the receipt of TAVR vs. SAVR in the real-world hospital setting.
  • After adjusting for baseline characteristics, no notable differences in death, AF, or ABE were observed between TAVR and SAVR cohorts. However, the lack of overlap in patient characteristics between cohorts resulted in a low effective sample sizes, which makes it difficult to detect meaningful differences if they truly existed.
  • Additional analyses with an amplified number of patients in the common support region would be needed to provide further insights into the relative safety of these procedures

Register to view this poster now!

By continuing to use the site, you agree to the use of cookies. More information.

The cookie settings on this website are set to "allow cookies" to give you the best browsing experience possible. If you continue to use this website without changing your cookie settings or you click "Accept" below, then you are consenting to this.